NDARECTALAEROSOL, METERED
Approved
Feb 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
Drug data last refreshed 5h ago · AI intelligence enriched 8h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CORTIFOAM is a metered-dose rectal aerosol formulation of hydrocortisone acetate, a topical corticosteroid approved in 1982 for treatment of inflammatory bowel conditions affecting the rectum and lower colon. It provides localized anti-inflammatory action at the site of rectal disease without significant systemic absorption.
$0.528MPart D
LOE ApproachingProduct approaching LOE with limited Part D activity ($528K spending, 799 claims in 2023) suggests a mature, niche specialty with small commercial team focused on retention and efficiency.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Pharmacokinetics and Bioavailability of Hydrocortisone Acetate Suppositories
Started Mar 2016
16 enrolled
Healthy
Career Relevance
Working on CORTIFOAM offers limited career growth due to product maturity, minimal Part D volume (799 claims), and approaching LOE status. Roles are focused on defensive commercial execution, compliance, and customer retention rather than innovation or market expansion.
Brand Manager
Worked on CORTIFOAM at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.